🇺🇸 FDA
Pipeline program

PV-10 (rose bengal disodium 10%)

PV-10-BC-04

Phase 1 small_molecule completed

Quick answer

PV-10 (rose bengal disodium 10%) for Breast Cancer is a Phase 1 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PROVECTUS BIOPHARMACEUTICALS, INC.
Indication
Breast Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials